🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We welcome the amazing Jose Obeso, Cynthia Sandor George Tofaris Esther Sammler / Sammler lab Caroline Williams-Gray, Frances Platt, Manji Kurian to join our own UCL speakers Nick Wood, Huw Morris Rimona Weil Kailash Bhatia, Tom Foltynie Harith Akram Christian Lambert Ed Jabbari Francesca Magrinelli

It's out! Neurology: A Queen Square Textbook amzn.eu/d/38X6oko Co-edited with Robin Howard, David Werring and @michael_zandi

Spaces are filling up fast! Register now to attend the UCL Movement Disorders Centre symposium on 10th June 2024! All are welcome to join us to hear about the latest movement disorders research. Scan the QR code or visit bit.ly/3O9gpRs to register today!

I'm really proud of this: 12 years of drug prioritization to help accelerate disease modification trials in #Parkinsons; Providing the background & learnings from Cure Parkinson's & Van Andel Institute (VAI)'s International Linked Clinical Trials initiative content.iospress.com/articles/journ…

Breaking news — Congress has passed The National Plan to End Parkinson’s Act! Passed unanimously by the U.S. Senate today, the bill now heads to President Biden’s desk to be signed into law. This is a historic milestone for the PD community, and we could not have done it without

Oooh interesting: Introducing C05-05, a small-molecule ligand for imaging α-synuclein pathologies in animal models and patients with #Parkinsons & related diseases; PET-detectable signals were intensified in the midbrains of PD & DLB patients (vs controls) cell.com/neuron/fulltex…

Seed amplification assays (SAAs) have developed rapidly over the past decade and are shaping the future of synucleinopathy diagnosis and research. Experts share their perspectives on a-syn SAAs as a developing methodology and what work needs to be done. loom.ly/Lgf0LoE

Great to be @ the EJS ACT-PD annual meeting! Tom Foltynie & CamilleBCarroll are opening proceedings with an update (& celebration!) of what has been achieved thus far in the consortiums efforts to build a MAMS platform for clinical trials of disease modifying drugs for #Parkinsons

Amazing day! What an inspirational group of people! So much has been achieved already with EJS ACT-PD! Congrats to CamilleBCarroll Tom Foltynie & team on fantastic progress. The future of #Parkinsons clinical trial research looked bright today. Cure Parkinson's is proud to support

Scientists at UCL and Universitätsmedizin Göttingen (UMG), including Dr Jenny Hallqvist, Professor Kevin Mills & Prof Kailash Bhatia, UCL Great Ormond Street Institute of Child Health UCL Queen Square Institute of Neurology have developed a blood test that uses artificial intelligence to predict #Parkinsons up to seven years before the onset of symptoms ucl.ac.uk/news/2024/jun/…

Today I signed the National Plan to End Parkinson’s Act – a law that will help prevent, treat, and cure Parkinson’s disease and similar disorders. This law is about dignity. It gives people hope that we can end this cruel disease and that we can still do big things.

"As President-Elect my vision would be to support the core values of the EAN in promoting education, science, advocacy & membership. I believe our future revolves around promoting diversity, education & fostering collaborations with other international forums & societies."

Many congratulations to SpillantiniLab for her Lifetime achievement award at #sfn24. Very richly deserved! All of us British Neuroscience Association send congratulations 🙌 🥂

Welcoming delegates for the National Meeting of the #ACORD Collaboration in London this afternoon! With Professor James Carpenter, Professor Jeremy Chataway and Professor Suvankar Pal MRC Clinical Trials Unit at UCL ICTM at UCL #NeurodegenerativeDiseases

Congratulations to the researchers at UCL and UCLH who have been recognised in the annual Clarivate listings of the most influential researchers around the world for 2024. The list features researchers judged to have exceptional #research influence. uclhospitals.brc.nihr.ac.uk/news/uclh-and-…

Delighted that our article on outcome measures for disease-modifying trials in #Parkinsons has been awarded JPD’s 2024 Best Clinical Research Prize! The result of teamwork and collaboration between researchers and #PwP in the EJS ACT-PD initiative, wonderfully led by anette schrag

Disappointing but extremely important results for Parkinson’s. Exenatide once a week versus placebo as a potential disease-modifying ... sciencedirect.com/science/articl…

Hi Masud, Have a read of; worldpdcongress.org/home/2018/7/27… 😉

Another great day yesterday at UCLH.. starting the #Ambroxol drugs trials for potential #Parkinsons treatment I encourage all to take part in #research with the fantastic medics, nurses and researchers.. it can be interesting, fun, positive, varied, helpful and much more.. 👩🏽

Are you part of the 96% of people who don't know about Corticobasal Degeneration? Help improve early diagnosis by watching our animation, It Could Be CBD. Professor Huw Morris shares the common symptoms to be aware of. Watch and share with colleagues here ow.ly/ugRQ50WbrPY